Notice of Meeting; Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Prevention, 63036 [2021-24807]

Download as PDF 63036 Federal Register / Vol. 86, No. 217 / Monday, November 15, 2021 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration khammond on DSKJM1Z7X2PROD with NOTICES Notice of Meeting; Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Prevention Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will convene via web conference on December 7, 2021, from 10:00 a.m. ET to 4:30 p.m. ET. The board will meet in open-session on December 7, 2021, from 10:00 a.m. ET to 11:55 a.m. ET, to discuss the Mandatory Guidelines for Federal Workplace Drug Testing Programs with updates from the Department of Transportation, the Nuclear Regulatory Commission, and the Department of Defense. Other discussion topics include a presentation on tetrahydrocannabinol isomerism and an update on the federal electronic custody and control form (eCCF). The board will meet in closed-session on December 7, 2021, from 1:00 p.m. to 4:30 p.m. ET, to review and discuss revisions to the Urine, Oral Fluid and Hair Mandatory Guidelines for Federal Workplace Drug Testing Programs, hair specimen proficiency testing, and hydroxy cocaine and cocaine ratios that have not been made public by the Department of Health and Human Services. Therefore, the meeting on December 7, 2021, from 1:00 p.m. ET to 4:30 p.m. ET, will be closed to the public, as determined by the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. 552b(9)(B) and 5 U.S.C. App. 2, Section 10(d). Meeting registration information can be completed at https:// snacregister.samhsa.gov/ MeetingList.aspx. Web conference and call information will be sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, https://www.samhsa.gov/ about-us/advisory-councils/meetings or by contacting the Acting Designated Federal Officer, Anastasia Donovan. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Drug Testing Advisory Board. VerDate Sep<11>2014 16:42 Nov 12, 2021 Jkt 256001 Dates/Time/Type: December 7, 2021, from 10:00 a.m. to 11:55 a.m. ET: OPEN, December 7, 2021, from 1:00 p.m. to 4:30 p.m. ET: CLOSED. Place: Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Contact: Anastasia Donovan, Policy Analyst, Center for Substance Abuse Prevention, 5600 Fishers Lane, Room 16N06B, Rockville, Maryland 20857, Telephone: (240) 276–1116, Email: anastasia.donovan@samhsa.hhs.gov. Dated: November 8, 2021. Carlos Castillo, Committee Management Officer. [FR Doc. 2021–24807 Filed 11–12–21; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0019] Vessel Entrance or Clearance Statement U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 60-Day Notice and request for comments; revision of an existing collection of information. AGENCY: The Department of Homeland Security, U.S. Customs and Border Protection will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). The information collection is published in the Federal Register to obtain comments from the public and affected agencies. DATES: Comments are encouraged and must be submitted (no later than January 14, 2022) to be assured of consideration. SUMMARY: Written comments and/or suggestions regarding the item(s) contained in this notice must include the OMB Control Number 1651–0019 in the subject line and the agency name. Please use the following method to submit comments: Email. Submit comments to: CBP_ PRA@cbp.dhs.gov. Due to COVID–19-related restrictions, CBP has temporarily suspended its ability to receive public comments by mail. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Requests for additional PRA information should be directed to Seth Renkema, PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Chief, Economic Impact Analysis Branch, U.S. Customs and Border Protection, Office of Trade, Regulations and Rulings, 90 K Street NE, 10th Floor, Washington, DC 20229–1177, telephone number 202–325–0056, or via email CBP_PRA@cbp.dhs.gov. Please note that the contact information provided here is solely for questions regarding this notice. Individuals seeking information about other CBP programs should contact the CBP National Customer Service Center at 877–227–5511, (TTY) 1–800–877–8339, or CBP website at https://www.cbp.gov/. SUPPLEMENTARY INFORMATION: CBP invites the general public and other Federal agencies to comment on the proposed and/or continuing information collections pursuant to the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.). This process is conducted in accordance with 5 CFR 1320.8. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) suggestions to enhance the quality, utility, and clarity of the information to be collected; and (4) suggestions to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. The comments that are submitted will be summarized and included in the request for approval. All comments will become a matter of public record. Overview of This Information Collection Title: Vessel Entrance or Clearance Statement. OMB Number: 1651–0019. Form Number: CBP Form 1300. Current Actions: Revision of an existing collection of information. Type of Review: Revision. Affected Public: Businesses. Abstract: CBP Form 1300, Vessel Entrance or Clearance Statement, was developed through agreement by the United Nations Intergovernmental Maritime Organization (IMO) in conjunction with the United States and various other countries. The form was E:\FR\FM\15NON1.SGM 15NON1

Agencies

[Federal Register Volume 86, Number 217 (Monday, November 15, 2021)]
[Notices]
[Page 63036]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-24807]



[[Page 63036]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting; Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will convene via web conference on December 7, 2021, from 
10:00 a.m. ET to 4:30 p.m. ET.
    The board will meet in open-session on December 7, 2021, from 10:00 
a.m. ET to 11:55 a.m. ET, to discuss the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs with updates from the 
Department of Transportation, the Nuclear Regulatory Commission, and 
the Department of Defense. Other discussion topics include a 
presentation on tetrahydrocannabinol isomerism and an update on the 
federal electronic custody and control form (eCCF). The board will meet 
in closed-session on December 7, 2021, from 1:00 p.m. to 4:30 p.m. ET, 
to review and discuss revisions to the Urine, Oral Fluid and Hair 
Mandatory Guidelines for Federal Workplace Drug Testing Programs, hair 
specimen proficiency testing, and hydroxy cocaine and cocaine ratios 
that have not been made public by the Department of Health and Human 
Services. Therefore, the meeting on December 7, 2021, from 1:00 p.m. ET 
to 4:30 p.m. ET, will be closed to the public, as determined by the 
Assistant Secretary for Mental Health and Substance Use, SAMHSA, in 
accordance with 5 U.S.C. 552b(9)(B) and 5 U.S.C. App. 2, Section 10(d).
    Meeting registration information can be completed at https://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/meetings or by contacting the Acting Designated 
Federal Officer, Anastasia Donovan.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention, Drug Testing 
Advisory Board.
    Dates/Time/Type: December 7, 2021, from 10:00 a.m. to 11:55 a.m. 
ET: OPEN, December 7, 2021, from 1:00 p.m. to 4:30 p.m. ET: CLOSED.
    Place: Substance Abuse and Mental Health Services Administration, 
5600 Fishers Lane, Rockville, MD 20857.
    Contact: Anastasia Donovan, Policy Analyst, Center for Substance 
Abuse Prevention, 5600 Fishers Lane, Room 16N06B, Rockville, Maryland 
20857, Telephone: (240) 276-1116, Email: 
[email protected].

    Dated: November 8, 2021.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2021-24807 Filed 11-12-21; 8:45 am]
BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.